Tim Anderson
Stock Analyst at B of A Securities
(0.98)
# 1921
Out of 5,326 analysts
33
Total ratings
64.71%
Success rate
1.68%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceut... | Maintains: Underperform | 575 547 | 599.33 | -8.73% | 2 | Apr 17, 2025 | |
JNJ Johnson & Johnson | Maintains: Neutral | 171 159 | 154.84 | 2.69% | 5 | Apr 10, 2025 | |
AARD Aardvark Therapeutic... | Maintains: Strong Buy | 22 26 | 8.27 | 214.39% | 2 | Mar 27, 2025 | |
GILD Gilead Sciences | Maintains: Strong Buy | 116 126 | 106.01 | 18.86% | 2 | Mar 5, 2025 | |
AMGN Amgen | Maintains: Underperform | 275 294 | 279.96 | 5.02% | 4 | Mar 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 200 223 | 180.79 | 23.35% | 5 | Mar 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 38 | 21.21 | 79.16% | 1 | Feb 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 41 34 | 27.34 | 24.36% | 2 | Feb 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 118 112 | 79.95 | 40.09% | 4 | Feb 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 29 | 22.8 | 27.19% | 1 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 63 | 48.66 | 29.47% | 1 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 178 | 119.48 | 48.98% | 1 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 997 | 861.09 | 15.78% | 1 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 1 | May 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 1 | Sep 22, 2017 |